Dr. Ritchie Shoemaker & Dr. Scott McMahon - Mold Testing, Binders, and the Future of Mold Medicine

Description Dr. Ritchie Shoemaker discovered Chronic Inflammatory Response Syndrome (CIRS) over 25 years ago and authored the foundational research, biomarkers, and treatment protocol that the entire field of mold illness medicine is built on. He is the founder of Surviving Mold and has trained the small group of physicians worldwide certified to treat CIRS. Dr. Scott McMahon is Medical Director at MoldCo and has treated thousands of CIRS patients using the Shoemaker Protocol, with a focus on pediatric and adolescent cases. In this episode, we discuss: lab testing and the limitations of antibody-based mold panels; the current binder protocol, why CSM was replaced by colesevelam, and where natural binders fit; what to do when you can't leave a contaminated environment, including how to remediate for actinomycetes, endotoxins, and mold; MSH recovery and what the recent Frontiers paper shows; the path to an ICD code for CIRS; the certification program training the next generation of providers; Dr. Shoemaker's departure from Surviving Mold and where his research goes next; and how MoldCo is scaling access to evidence-based mold illness care. Learn more about MoldCo at moldco.com. Medical Disclaimer Clear the Air is for general informational and educational purposes only and does not constitute the practice of medicine, nursing, or other professional health care services, including the giving of medical advice. No doctor-patient relationship is formed through this podcast. References to specific tests, treatments, medications, supplements, or healthcare providers are not endorsements or recommendations. Any reliance on information provided through Clear the Air is solely at the user's own risk. The content is not a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay seeking medical advice from a qualified healthcare provider based on anything heard on this podcast. If you think you're having a medical emergency, contact your healthcare provider or call 911 immediately. Podcast Guest Disclosures Guests on Clear the Air may have financial interests, ownership stakes, advisory roles, or commercial relationships with companies or products mentioned during their appearances, including with MoldCo. The opinions and views expressed by guests are solely their own and do not necessarily represent the views or official policies of MoldCo, Clear the Air, its producers, or affiliated entities. We make no warranties about the completeness or accuracy of statements made by guests. All information is provided for general informational and educational purposes only. Clear the Air Disclosures Clear the Air is produced by MoldCo. Clinical care is provided separately by licensed providers through MoldCo's telehealth platform and is governed by MoldCo's clinical policies, not by podcast content.Some guests hold paid roles at MoldCo, including Dr. Scott McMahon, who serves as MoldCo's Medical Director and receives financial compensation in that capacity.Some episodes may include paid sponsorships, partnerships, or sponsored segments. These will be clearly identified during the episode or in the show notes.Some content may contain affiliate links, through which MoldCo may earn a commission on sales made through those links. These links may direct you to third-party websites with their own terms and privacy policies, which we encourage you to review.Statements made on Clear the Air about Chronic Inflammatory Response Syndrome (CIRS), mold illness, treatment protocols, biomarkers, or specific medications have not been evaluated by the FDA. CIRS is not currently recognized by an ICD code. Discussion of any treatment, medication, or testing approach is for educational purposes only and is not a recommendation for any individual.